Metraipolis › archive › dc_47fa8f7800d2

Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy — Europe PMC PMID:31273938

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/31273938
DOI
10.15252/emmm.201910293
License (as archived)
solo-consultazione
Archived
2026-10-08T05:23:28.680Z
SHA-256 of the archived text
8980616d60520d246e3e78e9ffc0bb30a51914f08649a1bc3b370bdd88c9b3be
Stable URL of this page
https://metraipolis.com/documento/dc_47fa8f7800d2

How to cite

Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy — Europe PMC PMID:31273938 — Europe PMC (en), https://europepmc.org/article/MED/31273938 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_47fa8f7800d2 (Metraipolis archive dc_47fa8f7800d2, sha256 8980616d60520d246e3e78e9ffc0bb30a51914f08649a1bc3b370bdd88c9b3be)
BibTeX
@misc{dc47fa8f7800d2,
  title = {Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy — Europe PMC PMID:31273938},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/31273938},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_47fa8f7800d2; sha256 8980616d60520d246e3e78e9ffc0bb30a51914f08649a1bc3b370bdd88c9b3be},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/31273938. Agents can read the archived copy with the MCP tool read_document.